Nanobiotix ratios data for the quarter ended Dec 2025. These financial ratios cover 13 quarters of results from Dec 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2018 | Dec2019 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | |||||||||||||
| Assets AverageAssets Avg. | 57.47M | 154.51M | 132.82M | 101.23M | 73.50M | 52.49M | 72.51M | 97.19M | 82.69M | 61.59M | 65.01M | ||
| Invested CapitalInvested Cap. | 47.17M | 146.03M | 117.36M | 89.23M | 55.58M | 31.95M | 6.56M | 53.12M | 29.50M | -15.12M | -19.56M | 13.46M | |
| Leverage & Solvency | |||||||||||||
| Debt Ratio | 0.43 | 0.79 | 0.39 | 0.45 | 0.50 | 0.62 | 0.98 | 1.48 | 0.55 | 0.57 | 0.76 | 1.14 | 1.42 |